Flagship explainer
What drives IRADIMED CORPORATION’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $22.5M | FY2025 |
| |
| Income before tax | $28.4M | FY2025 |
|
| Operating income | $26.1M | FY2025 |
|
| $83.8M | FY2025 |
| |
| Ending assets | $109M | FY2025 |
|
| Beginning assets | $98.3M | FY2024 |
|
| $94.6M | FY2025 |
| |
| $86.8M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-024691